Background. There are few data on the mechanism of recurrent neurological events after transcatheter closure of patent foramen ovale (PFO) in cryptogenic stroke or TIA. Methods. We retrospectively reviewed PFO closure procedures for the secondary prevention of cryptogenic stroke/TIA performed between 1999 and 2014 in Bologna, Italy. Results. Written questionnaires were completed by 402 patients. Mean follow-up was 7 ± 3 years. Stroke recurred in 3.2% (0.5/100 patients-year) and TIA in 2.7% (0.4/100 patients-year). Ninety-two percent of recurrent strokes were not cryptogenic. Recurrent stroke was noncardioembolic in 69% of patients, AF related in 15% of patients, device related in 1 patient, and cryptogenic in 1 patient. AF was diagnosed aft...
Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ova...
AbstractObjectivesThis study sought to identify predictors of recurrent ischemic neurologic events w...
Background: The optimal strategy of secondary stroke prevention in patients with patent foramen oval...
Background: The optimal management of patients with cryptogenic ischemic stroke found to have a pate...
INTRODUCTION Patent foramen ovale (PFO)-closure is recommended for stroke prevention in selected ...
BACKGROUND: The clinical benefit of patent foramen ovale (PFO) closure after cryptogenic stroke has ...
Background: The ideal treatment strategy for patients with cryptogenic stroke and patent foramen ova...
ObjectivesWe sought to determine safety, recurrence rates, and novel risk factors for recurrence in ...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
AbstractObjectivesThe present study was conducted to determine the safety of the transcatheter closu...
Background: Paradoxical embolism due to the presence of patent foramen ovale (PFO) is a well-establi...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
© Springer-Verlag GmbH Germany, part of Springer Nature 2018A patent foramen ovale (PFO) is a highly...
ObjectivesThe purpose of this study was to compare the efficacy of medical treatment with percutaneo...
Background The aim of this study was to compare the immediate and long-term clinical outcomes of med...
Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ova...
AbstractObjectivesThis study sought to identify predictors of recurrent ischemic neurologic events w...
Background: The optimal strategy of secondary stroke prevention in patients with patent foramen oval...
Background: The optimal management of patients with cryptogenic ischemic stroke found to have a pate...
INTRODUCTION Patent foramen ovale (PFO)-closure is recommended for stroke prevention in selected ...
BACKGROUND: The clinical benefit of patent foramen ovale (PFO) closure after cryptogenic stroke has ...
Background: The ideal treatment strategy for patients with cryptogenic stroke and patent foramen ova...
ObjectivesWe sought to determine safety, recurrence rates, and novel risk factors for recurrence in ...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
AbstractObjectivesThe present study was conducted to determine the safety of the transcatheter closu...
Background: Paradoxical embolism due to the presence of patent foramen ovale (PFO) is a well-establi...
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The dilemma o...
© Springer-Verlag GmbH Germany, part of Springer Nature 2018A patent foramen ovale (PFO) is a highly...
ObjectivesThe purpose of this study was to compare the efficacy of medical treatment with percutaneo...
Background The aim of this study was to compare the immediate and long-term clinical outcomes of med...
Previous systematic reviews and meta-analyses compared the efficacy and safety of patent foramen ova...
AbstractObjectivesThis study sought to identify predictors of recurrent ischemic neurologic events w...
Background: The optimal strategy of secondary stroke prevention in patients with patent foramen oval...